BlackRock’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BlackRock’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-56,301	Closed	-$9.73M	–	3358
2015 Q1	$9.73M	Sell	56,301 -736	-1%	-$108K	0.01%	688
2014 Q4	$6.56M	Buy	57,037 +22,444	+65%	+$2.72M	0.01%	768
2014 Q3	$5.41M	Sell	34,593 -24,060	-41%	-$3.49M	0.01%	799
2014 Q2	$7.24M	Buy	58,653 +55,383	+1,694%	+$6.12M	0.01%	754
2014 Q1	$339K	Sell	3,270 -4,409	-57%	-$451K	﹤0.01%	1412
2013 Q4	$691K	Sell	7,679 -32	-0.4%	-$2.55K	﹤0.01%	1268
2013 Q3	$516K	Buy	7,711 +3,855	+100%	+$266K	﹤0.01%	1244
2013 Q2	$255K	Buy	+3,856	New	+$221K	﹤0.01%	1431

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BlackRock's SLXP Position: Q2 2015 in Review

BlackRock sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 56,301 shares — an estimated $9.73M sold.

BlackRock first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $9.73M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

BlackRock reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
BlackRock sold 56,301 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $9.73M.
BlackRock first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
BlackRock's SALIX PHARMACEUTICALS LTD DEL position peaked at $9.73M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BlackRock's 13F filing for Q2 2015, filed 7 Aug 2015.